11 | Proteins (Proteins, Gene)FDA Link
01/2016
-
11/2007 |
9 | Amyloid (Amyloid Fibrils)IBA
04/2018
-
12/2010 |
7 | Biomarkers (Surrogate Marker)IBA
01/2018
-
01/2012 |
6 | Cholinergic Agents (Cholinergics)IBA
12/2022
-
05/2006 |
6 | Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA
12/2022
-
05/2006 |
6 | RadiopharmaceuticalsIBA
01/2018
-
03/2006 |
4 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2019
-
05/2003 |
4 | N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
01/2016
-
05/2008 |
4 | Glucose (Dextrose)FDA LinkGeneric
02/2015
-
11/2012 |
3 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
04/2017
-
12/2004 |
3 | PK 11195 (PK11195)IBA
01/2016
-
12/2010 |
3 | LigandsIBA
02/2012
-
12/2008 |
3 | Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2010
-
01/2003 |
2 | 8- ((E)- 4- fluoro- but- 2- enyl)- 3beta- p- tolyl- 8- aza- bicyclo(3.2.1)octane- 2beta- carboxylic acid methyl esterIBA
01/2019
-
01/2015 |
2 | Amyloid beta-PeptidesIBA
01/2018
-
02/2008 |
2 | pyridineIBA
09/2015
-
02/2008 |
2 | Oxidopamine (6 Hydroxydopamine)IBA
01/2015
-
07/2012 |
2 | Dopamine (Intropin)FDA LinkGeneric
02/2012
-
01/2008 |
2 | Valproic Acid (Depakote)FDA LinkGeneric
04/2011
-
02/2010 |
2 | 2,3-dihydro-1H-imidazo(1,2-b)pyrazole (IMPY)IBA
12/2010
-
02/2008 |
2 | PrionsIBA
12/2010
-
02/2008 |
2 | N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA
07/2003
-
05/2003 |
1 | fluoroethoxy-benzovesamicolIBA
12/2022 |
1 | EstersIBA
12/2019 |
1 | BoronIBA
12/2019 |
1 | Cocaine (Cocaine HCl)IBA
01/2019 |
1 | florbetapirIBA
04/2018 |
1 | Protein AggregatesIBA
01/2018 |
1 | Adenosine (Adenocard)FDA LinkGeneric
04/2017 |
1 | Folic Acid (Vitamin M)FDA LinkGeneric
04/2017 |
1 | Nitric Oxide Synthase (NO Synthase)IBA
04/2017 |
1 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2017 |
1 | EnzymesIBA
04/2017 |
1 | Purinergic Receptors (Receptors, Purine)IBA
04/2017 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
04/2017 |
1 | GlucuronidaseIBA
04/2017 |
1 | Matrix Metalloproteinases (MMPs)IBA
04/2017 |
1 | KynurenineIBA
04/2017 |
1 | Amino AcidsFDA Link
09/2015 |
1 | 6- chloro- 2- (4'- iodophenyl)- 3- (N,N- diethyl)imidazo(1,2- a)pyridine- 3- acetamideIBA
09/2015 |
1 | GadoliniumIBA
09/2015 |
1 | acetamideIBA
09/2015 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2015 |
1 | N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamideIBA
01/2015 |
1 | NicotineFDA Link
01/2015 |
1 | Quinolinic AcidIBA
01/2014 |
1 | 2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
05/2013 |
1 | GD3 ganglioside (GD(3))IBA
05/2013 |
1 | MetalsIBA
05/2013 |
1 | IonsIBA
05/2013 |
1 | 2- (1- (6- ((2- fluoroethyl)(methyl)amino)- 2- naphthyl)ethylidene)malononitrileIBA
01/2013 |
1 | thioflavin TIBA
11/2012 |
1 | Peptides (Polypeptides)IBA
11/2012 |
1 | RiluzoleFDA LinkGeneric
01/2012 |
1 | Misoprostol (Cytotec)FDA LinkGeneric
04/2011 |
1 | TeratogensIBA
04/2011 |
1 | Ethanol (Ethyl Alcohol)IBA
04/2011 |
1 | Thalidomide (Thalomid)FDA Link
04/2011 |
1 | Dietary Fats (Dietary Fat)IBA
07/2008 |
1 | PregnenoloneIBA
05/2008 |
1 | benzovesamicolIBA
11/2007 |
1 | alpha-conotoxin MIIIBA
12/2004 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2003 |
1 | Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
06/2002 |
1 | Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2002 |